Da Fu
- Cancer Research top 0.5%
- MicroRNA in disease regulation 38
- Cancer-related molecular mechanisms research 34
- Molecular Biology top 2%
- Circular RNAs in diseases 28
- RNA modifications and cancer 27
- Ubiquitin and proteasome pathways 14
- Oncology top 5%
- Immunology top 5%
- Cell Biology top 5%
-
- Cancer Mechanisms and Therapy 10
-
- Plant-Microbe Interactions and Immunity 9
-
- Ferroptosis and cancer prognosis 9
- Journals
- PLoS ONE (15 papers)Molecular Therapy — Oncolytics (6 papers)Technology in Cancer Research & Treatment (4 papers)
- Partner nations
- ChinaUnited StatesTanzania
In The Last Decade
Da Fu
161 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 1.9k
- Molecular Biology 3.1k
- Oncology 922
- Immunology 567
- Cell Biology 341
Countries citing papers authored by Da Fu
This map shows the geographic impact of Da Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Fu more than expected).
Fields of papers citing papers by Da Fu
This network shows the impact of papers produced by Da Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Fu. The network helps show where Da Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Da Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 88 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 42 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 24 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 77 | |
| 14 | 2018 | 35 | |
| 15 | 2011 | 15 | |
| 16 | 2011 | 67 | |
| 17 | A New Species of Armeniaca Scop. from China | 2010 | 6 |
| 18 | Two New Species of Yulania Spach from Sichuan Province of China | 2010 | 3 |
| 19 | New Viewpoints on the Species of Xinyi and Mulan | 2002 | 0 |
| 20 | Notes on Yulania Spach | 2001 | 5 |
About Da Fu
Da Fu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 165 papers that have together received 5.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (38 papers), Cancer-related molecular mechanisms research (34 papers), Circular RNAs in diseases (28 papers), RNA modifications and cancer (27 papers), Ubiquitin and proteasome pathways (14 papers), Cancer Mechanisms and Therapy (10 papers), Plant-Microbe Interactions and Immunity (9 papers) and Ferroptosis and cancer prognosis (9 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (3.1k citations) and Oncology (922 citations). Da Fu has collaborated with scholars based in China, United States and Tanzania. Frequent co-authors include Yu‐Shui Ma, Xizhong Shen, Ting Yu, Ying Fang, Cui Sun, Zhongwei Lv, Wen Li, Xiaodong Zheng, Jibin Liu and Yi Shi. Their work appears in journals such as PLoS ONE, Molecular Therapy — Oncolytics, Technology in Cancer Research & Treatment, Nature Communications and Cell Biochemistry and Function.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.